Peer-influenced content. Sources you trust. No registration required. This is HCN.

Pharmacy Practice NewsNew Opioid 10 Times Stronger Than Fentanyl Approved Despite Abuse Concerns

Sufentanil sublingual tablet 30 mcg (Dsuvia, AcelRx), an effective novel tablet formulation of the synthetic opioid sufentanil, has been given FDA approval for the management of severe acute pain in adult patients in licensed medically supervised healthcare settings. The medication is administered sublingually in a single-dose, prefilled applicator.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form